These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11314677)

  • 1. Effects of methadone on cognition, mood and craving in detoxifying opiate addicts: a dose-response study.
    Curran HV; Kleckham J; Bearn J; Strang J; Wanigaratne S
    Psychopharmacology (Berl); 2001 Mar; 154(2):153-60. PubMed ID: 11314677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a single 50% extra dose of methadone on heroin craving and mood in lower- versus higher-dose methadone patients.
    Strasser J; Wiesbeck GA; Meier N; Stohler R; Dürsteler-Macfarland KM
    J Clin Psychopharmacol; 2010 Aug; 30(4):450-4. PubMed ID: 20571436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of methadone plus alcohol on cognitive performance in methadone-maintained volunteers.
    Kleykamp BA; Vandrey RG; Bigelow GE; Strain EC; Mintzer MZ
    Am J Drug Alcohol Abuse; 2015 May; 41(3):251-6. PubMed ID: 25584897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Additional methadone increases craving for heroin: a double-blind, placebo-controlled study of chronic opiate users receiving methadone substitution treatment.
    Curran HV; Bolton J; Wanigaratne S; Smyth C
    Addiction; 1999 May; 94(5):665-74. PubMed ID: 10563031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescribing methadone for the opiate addict: a problem of dosage conversion.
    Johns AR; Gossop M
    Drug Alcohol Depend; 1985 Sep; 16(1):61-6. PubMed ID: 4064909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response inhibition and psychomotor speed during methadone maintenance: impact of treatment duration, dose, and sleep deprivation.
    Bracken BK; Trksak GH; Penetar DM; Tartarini WL; Maywalt MA; Dorsey CM; Lukas SE
    Drug Alcohol Depend; 2012 Sep; 125(1-2):132-9. PubMed ID: 22552256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Craving patterns in methadone maintenance treatment with dextromoramide as adjuvant.
    de Vos JW; Ufkes JG; van den Brink W; van Brussel GH; de Wolff FA
    Addict Behav; 1999; 24(5):707-13. PubMed ID: 10574310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Buprenorphine/naloxone versus methadone and lofexidine in community stabilisation and detoxification: A randomised controlled trial of low dose short-term opiate-dependent individuals.
    Law FD; Diaper AM; Melichar JK; Coulton S; Nutt DJ; Myles JS
    J Psychopharmacol; 2017 Aug; 31(8):1046-1055. PubMed ID: 28631527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of buspirone in the treatment of opioid withdrawal.
    Buydens-Branchey L; Branchey M; Reel-Brander C
    J Clin Psychopharmacol; 2005 Jun; 25(3):230-6. PubMed ID: 15876901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detoxification of opiate addicts with multiple drug abuse: a comparison of buprenorphine vs. methadone.
    Seifert J; Metzner C; Paetzold W; Borsutzky M; Passie T; Rollnik J; Wiese B; Emrich HM; Schneider U
    Pharmacopsychiatry; 2002 Sep; 35(5):159-64. PubMed ID: 12237786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychobiological responses to drug cues before and after methadone intake in heroin-dependent patients: a pilot study.
    Walter M; Wiesbeck GA; Bloch N; Aeschbach S; Olbrich HM; Seifritz E; Dürsteler-MacFarland KM
    Eur Neuropsychopharmacol; 2008 May; 18(5):390-3. PubMed ID: 18299189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose methadone produces superior opioid blockade and comparable withdrawal suppression to lower doses in opioid-dependent humans.
    Donny EC; Walsh SL; Bigelow GE; Eissenberg T; Stitzer ML
    Psychopharmacology (Berl); 2002 May; 161(2):202-12. PubMed ID: 11981600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methadone vs. buprenorphine/naloxone during early opioid substitution treatment: a naturalistic comparison of cognitive performance relative to healthy controls.
    Rapeli P; Fabritius C; Alho H; Salaspuro M; Wahlbeck K; Kalska H
    BMC Clin Pharmacol; 2007 Jun; 7():5. PubMed ID: 17565668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive performance in methadone maintenance patients: effects of time relative to dosing and maintenance dose level.
    Rass O; Kleykamp BA; Vandrey RG; Bigelow GE; Leoutsakos JM; Stitzer ML; Strain EC; Copersino ML; Mintzer MZ
    Exp Clin Psychopharmacol; 2014 Jun; 22(3):248-256. PubMed ID: 24548244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methadone dose increase and abstinence reinforcement for treatment of continued heroin use during methadone maintenance.
    Preston KL; Umbricht A; Epstein DH
    Arch Gen Psychiatry; 2000 Apr; 57(4):395-404. PubMed ID: 10768702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heroin anticraving medications: a systematic review.
    Fareed A; Vayalapalli S; Casarella J; Amar R; Drexler K
    Am J Drug Alcohol Abuse; 2010 Nov; 36(6):332-41. PubMed ID: 20955107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of the dose on the severity of opiate withdrawal symptoms during methadone detoxification.
    Glasper A; Gossop M; de Wet C; Reed L; Bearn J
    Pharmacology; 2008; 81(2):92-6. PubMed ID: 17952010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The processing of automatic thoughts of drug use and craving in opiate-dependent individuals.
    Weinstein AM; Feldtkeller BT; Law F; Myles J; Nutt DJ
    Exp Clin Psychopharmacol; 2000 Nov; 8(4):549-53. PubMed ID: 11127426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [High-dose methadone detoxification in a hospital unit. Clinical experience].
    Ochoa E; Salvador E; Madoz-Gúrpide A; Lázaro M
    Adicciones; 2008; 20(3):245-9. PubMed ID: 18813771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Punishment induces risky decision-making in methadone-maintained opiate users but not in heroin users or healthy volunteers.
    Ersche KD; Roiser JP; Clark L; London M; Robbins TW; Sahakian BJ
    Neuropsychopharmacology; 2005 Nov; 30(11):2115-24. PubMed ID: 15999147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.